Author:
Mamdouhi Tania,Twomey Julianne D.,McSweeney K. Melodi,Zhang Baolin
Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Seyfried, T. N., & Huysentruyt, L. C. (2013). On the origin of cancer metastasis. Critical Reviews in Oncogenesis, 18(1–2), 43–73.
2. Moon, D. H., Lindsay, D. P., Hong, S., & Wang, A. Z. (2018). Clinical indications for, and the future of, circulating tumor cells. Advanced Drug Delivery Reviews, 125, 143–150.
https://doi.org/10.1016/j.addr.2018.04.002
.
3. Marusyk, A., & Polyak, K. (2010). Tumor heterogeneity: causes and consequences. Biochimica et Biophysica Acta, 1805(1), 105–117.
https://doi.org/10.1016/j.bbcan.2009.11.002
.
4. Administration, F. a. D. (2005). 510(k) substantial equivalence determination decision summary- Veridex, LLC (K050245).
5. Administration, F. a. D. (2010). Special 510(k) Device modification ODE review memorandum- Veridex, LLC (K103502).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献